Sangamo Therapeutics
SGMO
#10433
Rank
NZ$52.82 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-87.21%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.19 Billion a decrease over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion1.69%
2025 -NZ$0.19 Billion9.71%
2024 -NZ$0.17 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.32 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$97.13 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$80.75 Million75.62%
2014 -NZ$45.98 Million0.13%
2013 -NZ$45.92 Million
2011 -NZ$61.73 Million43.66%
2010 -NZ$42.97 Million28.52%
2009 -NZ$33.44 Million-23.55%
2008 -NZ$43.74 Million2.45%
2007 -NZ$42.69 Million19.5%
2006 -NZ$35.73 Million50.78%
2005 -NZ$23.7 Million75%
2004 -NZ$13.54 Million-33.25%
2003 -NZ$20.29 Million-62.27%
2002 -NZ$53.76 Million102.82%
2001 -NZ$26.51 Million23.21%
2000 -NZ$21.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.76 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.65 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.79 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.36 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.48 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.66 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.49 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.66 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA